206. Fragile X syndrome
98 clinical trials,   73 drugs   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways

Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01120626
(ClinicalTrials.gov)
September 20097/5/2010Randomized Controlled Study of Donepezil in Fragile X SyndromeAugmentation of the Cholinergic System in Fragile X Syndrome: A Double-Blind Placebo-Controlled Randomized Study of DonepezilFragile X SyndromeDrug: donepezil;Drug: sugar pillStanford UniversityNational Institute of Mental Health (NIMH);Autism SpeaksCompleted12 Years29 YearsAll45Phase 2United States
2NCT00220584
(ClinicalTrials.gov)
July 200515/9/2005An Open-Label Trial of Donepezil in Fragile X SyndromeAn Open-Label Trial of Donepezil in Fragile X SyndromeFragile X SyndromeDrug: donepezilStanford UniversityNULLCompleted14 YearsN/ABoth10Phase 1United States